Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

ClinicalTrials.gov ID: NCT07090161

Public ClinicalTrials.gov record NCT07090161. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 6:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iloperidone for the Treatment of Participants with Uncontrolled Hypertension

Study identification

NCT ID
NCT07090161
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
240 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 14, 2025
Primary completion
Sep 30, 2026
Completion
Oct 31, 2026
Last update posted
Feb 26, 2026

2025 – 2026

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
Vanda Investigative Site Phoenix Arizona 85053 Not yet recruiting
Vanda Investigative Site Tempe Arizona 85281 Recruiting
Vanda Investigative Site Tucson Arizona 85715 Not yet recruiting
Vanda Investigative Site Chula Vista California 91910 Recruiting
Vanda Investigative Site Dublin California 94568 Recruiting
Vanda Investigative Site Valencia California 91355 Not yet recruiting
Vanda Investigative Site Walnut Creek California 94596 Recruiting
Vanda Investigative Site Doral Florida 33172 Not yet recruiting
Vanda Investigative Site Fort Myers Florida 33912 Recruiting
Vanda Investigative Site Columbus Georgia 31904 Recruiting
Vanda Investigative Site Oak Brook Illinois 60523 Recruiting
Vanda Investigative Site Tinley Park Illinois 60477 Recruiting
Vanda Investigative Site El Dorado Kansas 67042 Recruiting
Vanda Investigative Site Wichita Kansas 67226 Recruiting
Vanda Investigative Site Lexington Kentucky 40509 Recruiting
Vanda Investigative Site Hazelwood Missouri 63042 Recruiting
Vanda Investigative Site Las Vegas Nevada 89119 Not yet recruiting
Vanda Investigative Site Mount Kisco New York 10549 Not yet recruiting
Vanda Investigative Site Rochester New York 14609 Not yet recruiting
Vanda Investigative Site Kinston North Carolina 28501 Recruiting
Vanda Investigative Site Cincinnati Ohio 45212 Recruiting
Vanda Investigative Site Norman Oklahoma 73069 Recruiting
Vanda Investigative Site Oklahoma City Oklahoma 73112 Not yet recruiting
Vanda Investigative Site Charleston South Carolina 29414 Recruiting
Vanda Investigative Site Carrollton Texas 75006 Not yet recruiting
Vanda Investigative Site Salt Lake City Utah 84124 Not yet recruiting
Vanda Investigative Site Burke Virginia 22015 Recruiting
Vanda Investigative Site Norfolk Virginia 23502 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07090161, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 26, 2026 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07090161 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →